Literature DB >> 18021891

Quality of life in patients with psoriasis and psoriasis arthritis with a special focus on stigmatization experience.

Gerhard Schmid-Ott1, Sabine Schallmayer, Iris Tatjana Calliess.   

Abstract

Negative impact of psoriasis and psoriasis arthritis on quality of life is a central consequence of these diseases. Feelings of stigmatization might, for example, already emerge with only small patches of skin being affected. Empirical data indicate that treating dermatologists should address possible negative effects elicited by problematic encounters with the public and in sexual relationships even if the severity of the disease is low, because lesions on invisible parts of the body can already cause serious adverse impairment. Such psychosocial consequences can be reduced by attending a self-help organization and by taking part in an interdisciplinary patient education program led by dermatologists.

Entities:  

Mesh:

Year:  2007        PMID: 18021891     DOI: 10.1016/j.clindermatol.2007.08.008

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  17 in total

Review 1.  Management of psoriatic arthritis from the view of the dermatologist.

Authors:  Caroline A Chang; Alice B Gottlieb; Paul F Lizzul
Journal:  Nat Rev Rheumatol       Date:  2011-09-13       Impact factor: 20.543

Review 2.  The burden of moderate to severe psoriasis: an overview.

Authors:  Giovanna Raho; Daniela Mihajlova Koleva; Livio Garattini; Luigi Naldi
Journal:  Pharmacoeconomics       Date:  2012-11-01       Impact factor: 4.981

3.  Stigmatizing attitudes toward persons with psoriasis among laypersons and medical students.

Authors:  Rebecca L Pearl; Marilyn T Wan; Junko Takeshita; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2018-08-29       Impact factor: 11.527

4.  Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study.

Authors:  Maddalena Napolitano; Luisa Costa; Francesco Caso; Matteo Megna; Raffaele Scarpa; Nicola Balato; Fabio Ayala; Anna Balato
Journal:  Clin Rheumatol       Date:  2017-05-31       Impact factor: 2.980

5.  Potential role of ustekinumab in the treatment of chronic plaque psoriasis.

Authors:  Santo Raffaele Mercuri; Luigi Naldi
Journal:  Biologics       Date:  2010-05-25

6.  Disease Severity, Quality of Life, and Psychiatric Morbidity in Patients With Psoriasis With Reference to Sociodemographic, Lifestyle, and Clinical Variables: A Prospective, Cross-Sectional Study From Lahore, Pakistan.

Authors:  Abdul Rahman Khawaja; Syed Muhammad Azam Bokhari; Rasheed Tariq; Shahzad Atif; Hanif Muhammad; Qadeer Faisal; Mohammad Jafferany
Journal:  Prim Care Companion CNS Disord       Date:  2015-06-25

7.  Psychological Distress, Alexithymia and Alcohol Misuse in Patients with Psoriasis: A Cross-Sectional Study.

Authors:  Ourania Founta; Karoline Adamzik; Anne-Marie Tobin; Brian Kirby; David Hevey
Journal:  J Clin Psychol Med Settings       Date:  2019-06

8.  Anticipated and Perceived Stigma Among Patients With Psoriasis.

Authors:  Marilyn T Wan; Rebecca L Pearl; Zelma C Chiesa Fuxench; Junko Takeshita; Joel M Gelfand
Journal:  J Psoriasis Psoriatic Arthritis       Date:  2020-06-08

9.  Hope as a Psychological Factor Affecting Quality of Life in Patients With Psoriasis.

Authors:  Beata Szramka-Pawlak; Elżbieta Hornowska; Hanna Walkowiak; Ryszard Zaba
Journal:  Appl Res Qual Life       Date:  2013-03-07

Review 10.  Targeting of interleukin-17 in the treatment of psoriasis.

Authors:  Ann Sophie Lønnberg; Claus Zachariae; Lone Skov
Journal:  Clin Cosmet Investig Dermatol       Date:  2014-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.